Ogedegbe Gbenga
Department of Medicine ,Columbia University, New York, NY 10032, USA.
J Clin Hypertens (Greenwich). 2008 Aug;10(8):644-6. doi: 10.1111/j.1751-7176.2008.08329.x.
There is an obvious gap in the translation of clinical trial evidence into practice with regards to optimal hypertension control. The three major categories of barriers to BP control are patient-related, physician-related, and medical environment/health care system factors. Patient-related barriers include poor medication adherence, beliefs about hypertension and its treatment, depression, health literacy, comorbidity, and patient motivation. The most pertinent is medication adherence, given its centrality to the other factors. The most salient physician-related barrier is clinical inertia--defined, as the failure of health care providers to initiate or intensify drug therapy in a patient with uncontrolled BP. The major reasons for clinical inertia are: 1) overestimation of the amount of care that physicians provide; 2) lack of training on how to attain target BP levels; and 3) clinicians' use of soft reasons to avoid treatment intensification by adopting a "wait until next visit" approach in response to patients' excuses.
在将临床试验证据转化为关于最佳高血压控制的实践方面,存在明显差距。血压控制的三大类障碍是与患者相关的、与医生相关的以及医疗环境/医疗保健系统因素。与患者相关的障碍包括药物依从性差、对高血压及其治疗的看法、抑郁、健康素养、合并症以及患者动机。鉴于其对其他因素的核心作用,最相关的是药物依从性。与医生相关的最突出障碍是临床惰性——定义为医疗保健提供者未能对血压未得到控制的患者启动或强化药物治疗。临床惰性的主要原因是:1)高估医生提供的护理量;2)缺乏关于如何达到目标血压水平的培训;3)临床医生使用软性理由,通过采取“等到下次就诊”的方法来回应患者的借口,从而避免强化治疗。